5348042025-10-012025-12-315348042025-12-315348042025-04-012025-12-315348042025-10-012025-12-31in-capmkt:OtherExpenses1Member5348042025-04-012025-12-31in-capmkt:OtherExpenses1Member5348042025-10-012025-12-31in-capmkt:ReportableSegments1Member5348042025-10-012025-12-31in-capmkt:ReportableSegments2Member5348042025-04-012025-12-31in-capmkt:ReportableSegments1Member5348042025-04-012025-12-31in-capmkt:ReportableSegments2Member5348042025-10-012025-12-31in-capmkt:ReportableSegments1Member5348042025-10-012025-12-31in-capmkt:ReportableSegments2Member5348042025-04-012025-12-31in-capmkt:ReportableSegments1Member5348042025-04-012025-12-31in-capmkt:ReportableSegments2Member5348042025-10-012025-12-31in-capmkt:ReportableSegments1Member5348042025-12-31in-capmkt:ReportableSegments1Member5348042025-10-012025-12-31in-capmkt:ReportableSegments2Member5348042025-12-31in-capmkt:ReportableSegments2Member5348042025-10-012025-12-31in-capmkt:ReportableSegments1Member5348042025-12-31in-capmkt:ReportableSegments1Member5348042025-10-012025-12-31in-capmkt:ReportableSegments2Member5348042025-12-31in-capmkt:ReportableSegments2Member5348042025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15348042025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15348042025-10-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss15348042025-04-012025-12-31ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRxbrli:pureiso4217:INRxbrli:shares534804CARERATINGNAINE752H01013CARE RATINGS LIMITEDMain BoardEquity2025-04-012026-03-312026-02-112026-02-02INRLakhsQuarterlyThird quarterMulti segment2026-02-1112:00:002026-02-1116:00:00Not applicable2025-10-012025-12-31UnauditedConsolidated112124200012990200012511440000005512570006470000369110001665680007612060004899380000489938000133390000-8848000124542000036539600000003653960001487000366883000358950000644600036061800062650003002500001011.9611.910011.9611.910001.The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at its meeting held on February 11, 2026 and have been subjected to limited review by the statutory auditors of the Company. <BR> 2. The consolidated financial results include results of CARE Ratings Limited and its subsidiaries namely CARE Analytics and Advisory Private Limited, CARE ESG Ratings Limited, CARE Ratings (Africa) Private Limited, CARE Ratings South Africa (Pty) Limited, CARE Ratings Nepal Limited and CareEdge Global IFSC Limited. <BR> 3. The accompanying financial results have been prepared as per the format prescribed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as modified by Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016. <BR> 4. The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended from time to time) read with section 133 of the Companies Act, 2013. <BR> 5. On November 21, 2025, the Government of India notified the four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. The Group has assessed and disclosed the incremental impact of these changes on the basis of the best information available, consistent with the guidance provided by the Institute of Chartered Accountants of India. The incremental gratuity impact of Rs.75.99 lakhs, arising primarily from the change in wage definition, has been recognised under Employee Benefit Expenses for the quarter ended December 31, 2025. The Group continues to monitor the finalisation of Central / State Rules and clarifications from the Government on other aspects of the Labour Code and would provide appropriate accounting effect on the basis of such developments as needed. <BR> 6. The Company has alloted 30,049 equity shares of Rs.10 each pursuant to excercise of employee stock options during Q3 FY 25-26. As per Ind AS 102 - Share Based Payment, total cost of ESOS 2020 is recognised over vesting period. <BR> Employee Benefit Expenses in Consolidated results includes ESOP charge for Q3 FY26 is Rs.24.80 and for 9M FY26 is Rs.136.36. <BR> 2025-04-012025-12-31UnauditedConsolidated342400400039107700038150810000001621061000186070001054670004364980002181633000163344800001633448000434334000-33580004309760000120247200000001202472000970700012121790001183423000190490001193104000190750003002500001039.4639.310039.4639.31000Other Expenses166568000Other Expenses436498000Ratings and related services997327000Others128144000Ratings and related services3057240000Others373401000112547100034306410004229000663700011212420003424004000Ratings and related services486722000Others-6447000Ratings and related services1618410000Others-119630004802750001606447000647000018607000-16133000-456080004899380001633448000Ratings and related services7942409000Others4528000008395209000213630600010531515000Ratings and related services1299915000Others377390000167730500001677305000Items that will not be reclassified to profit and loss-544000-544000Items that will not be reclassified to profit and loss-3545000-3545000-84000-774000Items that will be reclassified to profit and loss19470001947000Items that will be reclassified to profit and loss12478000124780000014870009707000